Karyopharm - oncology



















One month with a closing share price under $1. NASDAQ can formally start delisting process. Ricky.

6 months before the deficiency letter so little dickie will be madly trying to find someone to pump and dump to get the price above $1 for a couple weeks to buy some time screw everyone over before the exit. If no sucker to help out, pink sheets by May 2024.
 


























































































Why doesn’t the board put a stop to this?


What board? The same board that ousted MK and hired RP? That board? Better question is why isn’t the SEC doing anything? Why are none of our institutional investors doing anything?
My guess is, it’s small potatoes, many biotechs go belly up every year with very little fanfare.

This will be a, “hey what was the name of that company that had the first XPO1 inhibitor company that went out of business” situation. It will be forgotten like so many others…
 






What board? The same board that ousted MK and hired RP? That board? Better question is why isn’t the SEC doing anything? Why are none of our institutional investors doing anything?
My guess is, it’s small potatoes, many biotechs go belly up every year with very little fanfare.

This will be a, “hey what was the name of that company that had the first XPO1 inhibitor company that went out of business” situation. It will be forgotten like so many others…

Many of those companies had seasoned and competent senior management and they still failed. What hope is there for us?